Who’s Hired? New Mithra CEO Mulls Selling Generics Business
As Sawai Reorganizes Management And Coury Steps Down As Viatris Chair
• By David Wallace
Generate a summary of this article
Listen to this article
Mithra’s new CEO has immediately signaled a potential sale for the firm’s generics business as it looks to focus on branded assets in women’s health. Meanwhile, Sawai has reorganized its management team, the longtime chair of Viatris is moving on to another role, and a former AAM vice-president has joined Sandoz.
Mithra’s new CEO is considering selling its generics business • Source: Shutterstock
Just over a month into the position, Mithra’s new CEO David Solomon has signaled plans to potentially sell the firm’s generics business as it looks to focus on its branded assets in women’s health.
In a letter to shareholders, Solomon – who took over as Mithra CEO from Leon Van Rompay on 11 April...
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.